Walmart’s earnings have long been considered an unofficial gauge of consumer health, and on Thursday the company reported its slowest U.S. sales growth in years.

Shares of the world’s largest retailer fell 9% despite beating Wall Street’s earnings expectations. The company’s pharmacy business took a hit from federal Medicare negotiations that have reduced drug prices—an issue that CFO John David Rainey said will likely extend into next year.

Walmart also reported that it’s set to receive $2.9 billion in tariff refunds, which will go toward price relief for consumers.

This is a published version of the Forbes Daily newsletter, you can sign-up to get Forbes Daily in your inbox here.

Shares of Moderna retreated by nearly 24% Thursday on the heels of their record-setting 176% stock surge, which was prompted by promising news of their personalized cancer vaccine.

Charter Communications and Cox will merge into a single cable giant after their $34.5 billion deal closed on Thursday, with the new firm to be named Cox Communications.

The price of bitcoin surpassed $75,000 on Thursday, as President Donald Trump hosted crypto leaders at the White House and pushed Congress to pass the CLARITY Act, a bill that would establish a pro-crypto regulatory framework. Crypto markets also got a boost after the Treasury intervened in the bond markets, and Polymarket traders nearly........

© Forbes